| MethylPREDNISolone Sodium Succinate Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| MethylPREDNISolone Sodium Succinate 125 mg | powder for injection | injectable | 1.0 each | OTC |
| MethylPREDNISolone Sodium Succinate 1 g | powder for injection | injectable | 1.0 each | OTC |
| MethylPREDNISolone Sodium Succinate 40 mg | powder for injection | injectable | 1.0 each | OTC |
methylprednisolone sodium succinate - The sodium succinate salt of a synthetic glucocorticoid receptor agonist with immunosuppressive and anti-inflammatory effects. Methylprednisolone sodium succinate is converted into active prednisolone in the body, which activates glucocorticoid receptor mediated gene expression. This includes inducing synthesis of anti-inflammatory protein IkappaB-alpha and inhibiting synthesis of nuclear factor kappaB (NF-kappaB). As a result, proinflammatory cytokine production such as IL-1, IL-2 and IL-6 is down-regulated and cytotoxic T-lymphocyte activation is inhibited. Therefore, an overall reduction in chronic inflammation and autoimmune reactions may be achieved.